Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety, Tolerability, Pharmacodynamics, and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase (EE-TP) in Patients With MNGIE

NCT03866954 is registered in ClinicalTrials.gov with St George's, University of London as lead sponsor.

NCT NCT03866954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03866954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety, Tolerability, Pharmacodynamics, and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase (EE-TP) in Patients With MNGIE
Lead sponsor
St George's, University of London
Phase
Phase 2
Overall status
Withdrawn
Start date
November 30, 2024
Completion date
December 31, 2027
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

inborn errors of metabolism, metabolic disease, mitochondrial diseases